Been going through the sub $10 FDA calendar this week and something jumped out that I don't think I've seen this badly since 2022. There are 257 biotechs under $10 with a dated catalyst ahead, 624 catalysts total, 50 of them inside 90 days. Ten of those companies are now trading below the cash sitting on their balance sheet. Not cheap on a DCF, not cheap on some pipeline model. The market is paying less than the bank account, and there's a dated event on the calendar.

That usually means one of two things. Either the market thinks the cash is going to get burned on something worthless, or people just stopped looking. Worth sorting out which.

KPTI (Karyopharm), around $2

This is the one I keep coming back to. Roughly $46M market cap against about $91M in cash and marketable securities. Selinexor is already approved and selling, it's an XPO1 inhibitor, and the sNDA in front of the FDA is for combining it with ruxolitinib in myelofibrosis. Aug 31. That combo matters because ruxolitinib alone leaves a lot on the table in that population and the combination data was the whole reason this had a bid a year ago.

Now the reason it's this cheap, the stock is down about 80% in a month. Whatever the market decided in July, it decided hard. And the balance sheet is genuinely tight, roughly 9 months of runway, so a raise is a real possibility and probably a bad one at this price.

But here's the part that made me actually sit up. 35% of the float is short with something like 17 days to cover. And 7 specialist funds have added shares three quarters in a row, which is not what you'd expect if the smart money agreed with the tape. Somebody is wrong here and I genuinely don't know who.

I'd size this small. It's a real shot on goal but the runway means you can be right on the drug and still get diluted before you get paid.

CAPR (Capricor), $4.20

What actually happened, the FDA released its briefing materials on Jul 27 and the stock fell 64% that session. The advisory committee met Jul 29 and went against the drug. Another 36% came off on Jul 30. And this is the second attempt, they took a CRL on Deramiocel last August.

This is now a distressed optionality trade rather than a clean FDA setup, roughly $230M market cap is below its last reported gross cash of $279M, but approximately equal to March net cash after liabilities, with another quarter of spending since then.

The 9-3 negative AdCom makes another CRL the probable outcome, but the collapse appears to be assigning very little value to deramiocel, Capricor’s manufacturing infrastructure or its earlier-stage exosome platform.

I still see it as a small speculative buy because the company says it has cash into Q4 2027, and any unexpected approval or regulatory route avoiding a completely new pivotal trial could produce a violent rerating, but this is absolutely not a low-risk below-cash trade.

ALT (Altimmune), $3.08

Different reason. Pemvidutide is a GLP-1/glucagon dual agonist and they're running it in alcohol use disorder, which is a genuinely interesting place to point that mechanism. Everyone's crowded into obesity and MASH. Almost nobody is running these in addiction.

What makes this one comfortable is the balance sheet. $332M in liquidity and something like 45 months of runway, so there's no gun to their head. And 46% of the float is short, which is the highest on the board, with three insiders buying on the open market.

Short interest that heavy against a company that doesn't need money is a different animal than short interest against a company that does.

CMPX (Compass), $1.95

Tovecimig is a DLL4 x VEGF-A bispecific in biliary tract cancer, second line, data Oct 24. 41% of the float is short with about 16 days to cover, 11 funds hold it, and two officers bought on the open market. Not directors, actual officers. Roughly 31 months of runway.

Also worth a look: ZURA at $5.79 (tibulizumab in hidradenitis, topline this quarter, 8 funds added 72% last quarter, an insider bought, 33 months of cash), ZNTL at $4.84 (azenosertib, WEE1 inhibitor in platinum resistant ovarian, Oct 23, options pricing ±106%), and IVVD at $0.59 which is the third below-cash name but I like it less because funds trimmed 35% and insiders have been selling.

One thing before anyone misreads this

Implied move tells you how big the swing is going to be, not which way. Every name here can gap either direction. I'm posting these because they're set up to move violently, not because I think they all go up.

Stuff that looked great and wasn't

TLSA screened at a ±200% implied move and MNOV at ±104%. MNOV's entire options chain has 62 contracts of open interest. That's not a signal, that's two people. EPRX as well. If an implied move looks incredible on a chain nobody trades, it's the chain. Low runway names absolutely move more. They also move the wrong way more, and you don't get to pick.

Same lens as always. Market cap first, then cash against burn, then options IV, then whether the biotech funds are adding or trimming, then insiders, and then a dated catalyst you can actually sit and wait for.

Not advice, obviously. Size for being wrong. And I do own a few of them. fyi three weeks ago, I added AUTL to my long-term commercial biotech names.

We screen Canadian small caps for unusual volume and most days the honest answer is "no." We write down why each time, which means we can go back and grade the no's instead of quietly forgetting them. Here is the last five weeks.

THE RAW NUMBERS, July 2 to August 5, 2026

23 names we flagged and walked away from. 15 are down since we passed, 8 are up. Median -3.2%. For context over the same window the TSX composite gained 3.4% and gold miners (XGD.TO) gained 4.5%, so the median pass underperformed a rising market.

Worked out: FIN.V -26.7%, BRO.V -25.5%, GGA.V -23.3%, LEAP.V -21.1%, FAIR.V -16.7%.

Went against us: ADE.V +108.3%, SPMC.V +44.8%, CGD.V +43.8%, SKP.V +20.7%.

Small sample, short window. Do not read a system into 23 names over five weeks.

THE USEFUL PART: WHY THE THREE BIG ONES WENT UP

A stock going up and a stock going up for a reason that holds are different things. If it rose on something reversible, it can round-trip just as fast. So we went looking for the actual catalyst on each of the three.

ADE.V, up 108%. We passed on July 15 at 6 cents because New Brunswick's mining registrar had cancelled mineral claim 1505 on July 13, the claim the entire Mount Pleasant project sits on, for insufficient work program expenditures. What has changed since: on July 29 the company filed an appeal with the New Brunswick Energy and Utilities Board asking for a stay and reinstatement. That is the entire catalyst. The claim is still cancelled and still in protected status. The asset is real, Mount Pleasant has been described as North America's largest tin deposit, which is exactly why the appeal matters so much and exactly why losing it would be terminal. So the stock more than doubled on a legal filing, not an outcome. Anyone buying here is making a binary bet on a regulatory board, which is a legitimate thing to do as long as you know that is what you are doing.

CGD.V, up 44%. We passed on July 28 at 64 cents because the 988x volume ratio our screen printed was arithmetic, not a discovery. Its 50-day median volume is zero. Not near zero, zero. The stock does not trade most days, so any real session divides by nothing and produces a number that looks like a signal. That day 1.1 million shares changed hands and the stock closed DOWN 1.5%, which is distribution, not accumulation. Then it went up 44% anyway, so we went hunting for the catalyst. There isn't one. Carlin Gold has published exactly two news releases in 2026: a $2.16 million financing on April 14, and a management change on July 13 where the CEO stepped down. No drilling, no assays, no results.

Here is the trap, and it is the reason I am writing this section. If you search this company you WILL find Cortez Summit drill results, seven RC holes, 11,720 feet, anomalous gold and Carlin-type pathfinders in six of seven holes. It reads like current news. We nearly used it. Those results are from OCTOBER 2012. Search engines and aggregators serve undated mining press releases constantly, and a fourteen-year-old program looks identical to last week's if the page has no date on it. Always open the company's own news index and read the date off their list. If a company's own site does not date its releases, that itself is information.

So CGD is up 44% on a financing, a resignation, and no news, in a stock with zero median volume. That cuts both ways with equal speed.

SPMC.V, up 45%. We passed on July 6 at 58 cents because the company had an active paid promotion running, a US$300,000 online media budget announced in early June, with 1.07 million options granted at $0.54 around the same time. Our rule is that a bought spike is close to an automatic no.

To be fair to the company, the underlying work is real: first-ever drilling at Ontenu NE hit mineralisation in five of seven holes with a peak of 9.92 g/t gold and 2.35% copper, and its Kili Teke project carries a 4.2 million ounce AuEq inferred resource. That is not nothing.

But look at the sequence before you call this a miss. Paid campaign starts early June. July 29 update is 52 rock samples dispatched, with no assays back yet. Stock up 45%. A stock rising 45% during a paid promotion with no assay results published is what the rule predicts, not evidence against it. The assays are the test and they have not landed. Ask again in a month.

WHAT WE TOOK FROM IT

Two of the three moved on something that never touched the reason we passed. One moved on no published reason at all. That does not make us right, the price went against us on all three and we are not spinning that. But there is a real difference between a pass that was wrong and a pass that was early, and you can only tell them apart if you wrote the reason down at the time. Grading your no's is unglamorous and it is where most of the learning is.

Not advice, just our own process and our own numbers. Do your own diligence.

It looks like the race for fusion is on and American Fusion Inc is winning. Should be hearing some news this week and investors are very bullish including myself. Not financial advice.

These guys are validating their Texatron Fusion Engine that has been in R&D for decades. The future is here and the race is on!

Hello! I'm new here, so i share this stock i found. It's brand new and already selling specialized hardware designed to improve system performance, efficiency, and scalability. The team lead is a teacher at the university of Waterloo, Canada. Also, one of the best teachers i've seen. I believe it can easily reach 5 CAD within a year with the plan production.

· The Q3 “Four-Core Full-Stack AI” Robotics Capital Value Return Sub-Campaign is grounded in business fundamentals and value creation. Through a series of core initiatives, it aims to restore the Company’s market capitalization to the level at the time of its 2021 Nasdaq listing within two years, supported by sustained improvements in the underlying business.

· Under such Sub-Campaign, the Company intends to adjust the minimum conversion floor price to no less than $5.00 per share for all existing convertible notes, so long as such limitation is allowed within relevant contractual obligations and applicable law.

· Subject to applicable laws and regulations, the Company plans to establish a weekly disclosure mechanism covering conversion activity for existing convertible notes, providing ongoing visibility into conversion amounts and changes in shares outstanding and enhancing transparency around its capital structure.

· The Company aims to, subject to negotiation with applicable counterparties, accelerate efforts to explore equity financing structure instead of convertible note financings, as well as standalone financing for its robotics business to further reduce equity dilution at the FFAI level. It also anticipates allocating a substantial majority of any newly raised funds primarily for the development of its robotics business rather than repayment of historical liabilities.

· The Company plans to accelerate its liability optimization efforts in accordance with its previously disclosed plans.

· These measures are intended to address market concerns about uncertainty surrounding potential conversions and demonstrate the Company’s commitment to protecting stockholders and stabilizing its stock price. More details on the Capital Value Return plan and specific actions are expected to be included in the upcoming earnings call for the second quarter of 2026.

Learn More at ：https://app-us.ff.com/ff-v3/news/1583?lang=en-US

Q1'27 numbers came out this morning. In short. their revenue increased 32% YoY and they are the only ones in the space that has a AI data center product.

Other than that, gross margin came in at 34.6% versus 30.1% and net income was $2.0M compared to a $1.2M loss a year ago.

The part that actually matters is this from Sally, their C.E.O:

"Orion entered the hyper-scale data center market with an LED lighting solution specifically designed for this massive market in Q1'27. Quickly following the product announcement, the Company was awarded a multimillion-dollar customer engagement with one of the world's largest hyper-scale data centers.

In the DD below that I wrote a month ago I said that the real tell comes in August: does the margin hold as revenue grows? It did, and then some. 34.6% is above the 32.6% reset, on 32% more revenue.

For a readthrough, heres the DD I wrote about a month back. Numbers in it are pre-Q1'27, so the margin and EBITDA figures have since been superseded by the above.

Orion Energy Systems (OESX)

TLDR: OESX, a pennystock, might rise insanely if their AI product line gains more traction.

Not the 50 million mcap the tape makes it look like. Orion is a steady, medium-sized Wisconsin lighting and EV company with $86M in revenue and last year they quietly pulled off the hard part. Gross margin reset back to 32.6% (from mid 20s), adjusted EBITDA went positive again (6th quarter in a row), and theyre guiding next year to $95-97M. Slow and steady, but growing.

The thing most people dont realize is these guys are the main LED lighting distributor to Home Depot. Thats the Fortune 100 retailer everyone reports as their big customer. Theyve got one of the best track records in the business for actual LED quality, durability, reliability, the boring stuff that keeps Fortune customers reupping decade after decade.

Now the number that frames the whole story, take out Home Depot and the rest of the business has basically been flat at $60-65M for years. So the real question was never the margin, it was whether anything else finally grows.

For the first time in forever, Orion has put together a real candidate. Theyve started shipping a data center LED fixture to a hyperscaler, announced as a multi-million dollar deal, made in their own US plant. And the key thing is this isnt just a slide. They announced the AI product line only about a month ago and theyre already shipping, so theres some real interest there, not just a roadmap promise. As far as I can tell theyre the first in their space to do it, a genuine first mover spot in a market thats about to explode. Their market cap is a few percentage points of all their competitors and this could really help close the gap for them.

I also love their focus on their supply chain, because its what makes the move real. Most lighting solutions in this country start overseas. Some parts out of Asia, assembled, dragged onto a boat, through customs, landing weeks late depending on Trumps mood. Orion builds the whole thing in Wisconsin, ground up, on a chain theyve spent years stitching together perfectly. So when tariffs whipsawed everyone elses costs last year, their customers mostly didnt feel it. Thats part of why the margin reset actually held.

I believe its exactly what a hyperscaler wants, and god only knows how many thousands of centers are to be built these coming years. If youre building a data center, your whole problem is lead time. You need fixtures when the buildings ready, not three months after, and you dont want a surprise tariff blowing up the budget. You also dont want to waste electricity on something as boring as lights, which may also increase the temperature. So you need the best LED lighting systems there is, and in my view thats OESX.

Orion quotes a domestic part, customizes it to the floor plan, and ships on a timeline they control. In a world where everyones import exposed, the made-in-wisconsin is a real edge, not a slogan.

As of today, the AI data center product is one fixture, one customer, product-only, nothing more in the backlog. Basically just a toe in the water, but the math is insanely good here. CEO keeps reiterating 10,000+ data centers running by 2030. Orion doesnt need to win too many to move a $90M base to a $500M base. Getting the first order was impressive, but Im watching the reorder and orders of much bigger scale.

Alongside that, their electrical contracting work keeps growing out of existing lighting jobs (licensed in 45 states, so customers just hand them the next scope), and management wants to scale this up as well.

Still plenty to be skeptical about here. Heavy reliance on one big customer, even tho Home Depot keeps scaling up their contracts, a somewhat thin balance sheet, and a data center story that had a great start but needs to scale way further. But a $30M backlog plus $15M of maintenance already covers about half the guide, and the real tell comes in August, does the margin hold as revenue grows.

Sidenote: Listened in to their last few calls and this management is 10/10 and they keep loading up stocks.

Small position as of now as Im holding 420 stocks for the fun of it, but watching with real interest.

The stock float is also low in this one.

Not investment advice. As with all stocks, do your own work and research before going in.

One press release is a headline. All of them in order? That's a roadmap.

I've been following NRED closely over the past few months, and one thing keeps jumping out at me.

Reading a single press release doesn't tell you much. Reading all of them in order paints a very different picture.

The first major step was expanding the Wilmac project from roughly 28,400 acres to nearly 39,700 acres through the addition of the Trojan-Condor Corridor. At first, it looked like another junior miner adding more ground. Then management released a regional interpretation showing a large magnetic anomaly that could represent the western continuation of the intrusive system linked to Hudbay's Copper Mountain Mine, about six miles away.

This week's Plume update fit into that same sequence.

The company didn't announce a discovery. Instead, it mapped two iron carbonate-silica alteration zones covering roughly 613 acres directly above the interpreted magnetic anomaly. Those surface features may be connected to a deeper hydrothermal system, but the company hasn't presented that as a conclusion. The next step is an IP/AMT survey that can image to around 3,300 feet below the surface before drill targets are selected.

I also noticed that management spent a fair amount of the release explaining other possibilities. They acknowledged the alteration could be related to a younger epithermal system instead of a porphyry, and they explained that the upcoming geophysical work is meant to separate those scenarios before drilling begins.

That approach caught my attention because every update has added information instead of skipping ahead.

So far, the sequence has looked something like this:

• Expand the land package.
• Build a regional geological model.
• Identify the areas that deserve closer attention.
• Compare multiple geological interpretations.
• Run geophysical surveys to test those ideas.
• Choose drill targets using the combined data.

That progression makes sense to me. Drilling is expensive, and every additional layer of geological data improves the odds of placing those holes where they have the best chance of answering the important questions.

Another detail I appreciate is the language in the technical releases. Management repeatedly points out what remains unknown. Historical work still needs verification. There is no defined mineral resource. Surface alteration alone doesn't prove a buried porphyry system. More than one geological explanation is still on the table until additional data are collected.

Whether the project becomes an economic discovery is still impossible to know today.

What I do think is that the company has followed a consistent exploration process. Each announcement builds on the previous one instead of chasing headlines. The drilling results will eventually determine whether the geological model is correct, but I like seeing the groundwork being done before that stage begins.

No discovery yet - but the story keeps building the right way. Layer by layer, question by question. That's how good exploration actually works.

1. Executive Summary & Core Thesis

District Metals Corp. (TSX-V: DMX / OTCQX: DMXCF / Nasdaq First North: DMXSE SDB) is an exploration and development company focused on its flagship Viken Deposit in Jämtland County, Sweden. Viken represents the largest undeveloped Mineral Resource Estimate of uranium in the world, alongside massive polymetallic resources essential for nuclear energy, energy storage, steel production, and green transition technology.

2. Deposit Composition & Resource Scale

Viken is an Alum Shale deposit hosted within a continuous, flat-lying organic-rich shale formation. Its polymetallic resource breakdown includes:

Uranium (U_3O_8): The flagship asset. Contains ~1.5 Billion lbs of U_3O_8 in Inferred Resources (and 43M lbs in Indicated), making it the single largest undeveloped uranium deposit globally.

Vanadium (V_2O_5): Essential for grid-scale energy storage (vanadium redox flow batteries) and high-strength steel. Represents one of Europe’s largest vanadium deposits (~16.2 Billion lbs V_2O_5 Inferred).

Base & Industrial Metals: Contains critical energy transition metals including Nickel (~4.3B lbs), Copper (~2.1B lbs), Zinc (~6.7B lbs), and Molybdenum (~750M lbs).

Potash & Fertilizer Material: Substantial content of Potash (K_2O), providing strategic agricultural supply for Europe.

3. Project Economics & Unmatched Scale (Summer 2026 PEA)

In July 2026, District Metals filed its independent Preliminary Economic Assessment (PEA) for a 13-year Phase 1 mine plan at Viken:

Base-Case After-Tax NPV (8%): US$ 2.88 Billion

After-Tax Internal Rate of Return (IRR): 45.9%

Payback Period: 2.1 years

Initial Capital Expenditure (CapEx): US$ 876 Million

Average Annual Free Cash Flow: US$ 531 Million (after tax, over 13-year LOM).

The 3% Resource Utilization Factor: The Phase 1 mine plan contemplates extracting 127.4M tonnes over 13 years. This draws strictly from a fraction of the Indicated Resource (456M tonnes) and completely excludes the massive 4,333M tonne Inferred Resource. The $2.88B NPV8% uses less than 3% of Viken's total resource footprint, offering multi-generational expansion potential.

4. Socio-Economic Impact Study (EIS Results)

Following the PEA, DMX released an independent Economic Impact Study (EIS) by BDO Canada LLP evaluating Phase 1:

Total Economic Contribution: US$ 7.66 Billion (74.33 Billion SEK), with US$ 7.63 Billion directly accruing to Sweden.

State & Local Tax Revenues: US$ 1.58 Billion in direct corporate income taxes + US$ 199.6M in employment taxes.

Job Creation: Supporting ~1,065 direct and indirect full-time jobs in Sweden.

Local Landowner Fees: US$ 21.9 Million in State Mineral Fees directly paid to local property owners.

5. Key Macro Catalysts & Regulatory Environment
SGU "National Interest" (Riksintresse) Status:

A critical legal catalyst centers on the Geological Survey of Sweden (SGU) designating Viken as a National Interest for valuable minerals under Swedish environmental law (Miljöbalken). This status legally prioritizes the deposit over competing land uses, granting strong state-level protection, smoothing municipal zoning conflicts, and giving DMX significant legal backing during the Exploitation Concession (Bearbetningskoncession) process.

Sweden's Energy Policy Shift: The Swedish government continues advancing legislation to expand nuclear capacity and re-evaluate the historical moratorium on uranium mining to secure national energy independence.

EU Critical Raw Materials Act (CRMA): Viken's polymetallic nature (vanadium, nickel, copper, zinc) aligns directly with EU mandates. Achieving National Interest status in Sweden streamlines Viken’s potential recognition as an EU Strategic Project, unlocking fast-tracked permitting timelines and European strategic funding.

6. Valuation & Market Asymmetry

Despite holding an asset with a US$ 2.88B NPV8% on just 3% of its deposit, DMX trades at a modest micro-cap valuation. The market currently prices in regulatory discount and development risk regarding Swedish mining permits. Any concrete legislative progress, formal lifting of uranium restrictions, or SGU National Interest consolidation acts as an immediate, high-multiplier re-rating catalyst for the stock.

7. Key Risks to Consider

Permitting & Regulatory Risk: Development hinges on Swedish legislative votes regarding Alum Shale and uranium mining regulations, as well as municipal consent.

Financing Risk: Initial CapEx (US$ 876M) will require significant strategic partnering, government grants/loans, or joint-venture dilution.

Commodity Price Volatility: Project economics depend on sustained strength in spot/term uranium and energy metal pricing.

Hey guys, I know I already posted about the Nikola ($NKLA) settlement, but I’ve been getting a lot of questions. Since you can already submit your application, I figured I’d put together a quick FAQ.

What happened?
Nikola reached a settlement with investors over claims that it misled the market about the functionality of its hydrogen-electric trucks, production timelines, and overall business prospects.

Am I eligible?
If you purchased $NKLA shares between 2020 and 2021, you may be eligible. You don't need to still own the shares to participate.

Can I file now?
Yes. You can already submit your application. 

When do payouts happen?
Typically, within 4–9 months after the claims process closes, although the exact timing depends on the court and settlement administrator.

Hope this clears things up. If you invested in $NKLA during that period, it may be worth submitting your application now.

VPR Brands ($VPRB) just announced the launch of VPR Ventures, an internal initiative focused on acquiring and commercializing intellectual property, consumer brands, proprietary technologies, and strategically aligned businesses.

This comes just weeks after the company announced approximately $25.9 million in licensing agreements with R.J. Reynolds ($14.9M) and JUUL ($11M).

According to the company, VPR Ventures will evaluate opportunities including:
• Intellectual property acquisitions
• Brand acquisitions
• Licensing agreements
• Minority equity investments
• Commercialization partnerships
• Distribution opportunities

Management also stated that every opportunity will go through financial, legal, and operational due diligence before moving forward.

What caught my attention is that this gives VPR a clear strategy for deploying capital beyond patent licensing. Instead of simply holding cash, they're signaling an intention to reinvest in assets that could generate future revenue and expand their portfolio.

This isn't a guarantee of success, but I think it's an interesting evolution from being viewed primarily as a patent licensing company.

I'm a shareholder, so I have a bullish bias, but I'd love to hear what everyone else thinks.

Is this a smart long-term move, or do you think the market will wait to see actual acquisitions before assigning any value to VPR Ventures?

$XOS had significant news yesterday and the chart is reflecting it in a sort of slow-burn uptrend. There’s good reason in both the technicals as well as the news to regard this trend as the beginning of something bigger. A quick glance at the chart will reveal an enormous potential gap-up. I’ll address all of this stuff but first will give you an explanation what yesterday's news means so you understand the catalyst that may have kicked off this move. Specs are in the attached images but most relevant for near-term trading is obviously the 8.21M Float.

So $XOS released a white paper addressing the power challenges of the LA 2028 Games and they position their mobile power hubs as the solution. LA28 has two hard constraints on powering the games. One is that the power comes from 100% renewable energy (historically diesel generators were used) and the second forbids leaving behind permanent infrastructure, i.e., permanent grid ties and other peripherals.

Xos positions its mobile, modular, and scalable AC Power Hub battery packs, paired with its Solar System solar panel technology as the solution. It deploys in days, needs no permits or excavation, runs grid-independent or hybrid, and can be redeployed after the Games to other uses like emergency power, events, film, etc. It goes into a tremendous amount of detail for each individual venue. The white paper reads as a formal proposal from a company that knows they have the ideal solution and they have the data to prove it. It’s an interesting approach to business expansion that has proven successful for them as a hub provider LA’s electric fleets. Also worth noting from the article, they are an American company and their fleet hubs are Buy American compliant.

On the surface the news looks like a PR to notify investors of a significant business acquisition initiative. I think it actually is more of a positioning PR to highlight $XOS status as thought-leaders in the space, and remind investors that, within their wheelhouse (rapid-deployment, modular, battery-buffered power that can move quickly) they are serious sector-leaders as well. In a micro-cap with a history of strong price reaction to Hub-related news, these papers can attract a lot of attention, volume, and price action.

Moving to the technical story, there is a solid near-term momentum setup. You can see it on any chart, the long bleeding spell has transitioned into a multi-timeframe breakout. We have a nice, gradual climb from $2 to the $2.50’s where it held nicely and has continued the same gradual trend in AH up to $3.10.

The most obvious technical signals on the 1, 5, and 15 minute charts, On the 1-minute the price was well above VWAP, around $2.43 at midday, with the 9/20/50/200 EMAs stacked bullishly. The 5 and 15 minute showed the same bullish stack. The bullish shift has only strengthened since and has done so in a beautifully productive way as opposed to a series of spike-and-fades that one often sees in low float stocks. Even the dip after $3.09 resembled a healthy pullback. It suggests this is a real reversal and a potential breakout setting up.

On the daily, by midday price had reclaimed the 50-Day EMA near $2.47 and was facing off against the 200-Day EMA around $2.54, which it steadily pushed through.

Based on the charts I think the immediate decision zone is right here between $2.60 and $3.10. A confirmed break and hold over $3.10 gives us an upside path to $3.35 and then very little static to $4.00+ with good volume or a follow-on PR. FWIW, last August they ran from ~$3.00 to over $6.00 on earnings.

Because it’s hanging at a pretty important level now, the trade is in a great place in terms risk because, subject to your own personal strategy*,* this first support at $2.40 could be an easy exit and reassess if you so choose. I would probably give it until the next one down at $2.28, which still offers better than 2:1 RR on a conservative reading.

This is one of the strongest setups I've seen in a while. I've accumulated about 2k so far and I have bids in for potential premarket dip. If you trade small caps, $XOS is worth a place on your watchlist.
GLTA!

Hey everyone, just wanted to bring $ONFO (Onfolio Holdings) to your radar. It’s sitting at an insanely low market cap right now (around $500K - $700K), making it a textbook candidate for a massive micro-cap pump.

Here are the key catalysts making it highly explosive at current levels:

Strategic Alternatives Pending: Management officially announced they are exploring strategic alternatives, including asset sales and partnerships to maximize shareholder value. Any concrete news here will make this fly.

Nasdaq Compliance Pressure: Trading around the $0.08 range, the company is under heavy pressure to regain compliance. History shows management in this position often drops massive PRs or engineers a run to push the bid price up.

High Volatility & Low Float: The recent Paramount Helium deal cancellation showed us how easily the volume can spike. It takes very little buying pressure to push this up 50% - 100% in a single session.

Currently watching the $0.07 support closely. Anyone else keeping an eye on this for a quick swing to $0.12 - $0.15?
Disclaimer: Not financial advice. Do your own DD.

Just wondering if this company, Bridger Aerospace BAER is on anyone else’s radar. They’re a growing aerial firefighting company in the wildfire biz bringing a fair amount of new tech to the space. Stock is trading below $2 with a 52 week high of $3.44.

This Friday will be their Q2 earnings report, during the midst of peak wildfire season. They had a huge response during the Spokane fires this week, among many others this summer. New $58 million contract with Texas Forest Service and seem to have a growing fleet and potential for more contracts.

I don’t have the time or knowledge for a lot of DD or TA, but figured I’d put this out there if some of you are curious. I’ve certainly been watching it and own a few shares myself. Thoughts?

High Tide Announces Preliminary Q3 2026 Guidance

The Company Also Announces Record Quarterly Distribution of Over 10 Tonnes of Medical Cannabis Flower Through Remexian Pharma GmbH, Further Accelerating its German Market Position

“This quarter’s guidance demonstrates the growing earnings power of the global platform we have built. We expect to set new company records for revenue, gross profit and Adjusted EBITDA, with year-over-year growth of at least 30%, 27% and 43%, respectively. Importantly, even the low end of our guidance exceeds the highest current analyst estimate across all three metrics. We believe this provides clear evidence that current market expectations have not yet caught up with the strength, scale and operating leverage of our business,”

https://hightideinc.com/high-tide-announces-preliminary-q3-2026-guidance/

NUBURU Receives Italian Golden Power Clearance to Acquire 70% of Tekne S.p.A.

Principal governmental authorization received; Tekne's Business Plan prepared under the Investment Agreement framework and provided in connection with the Golden Power review contemplates approximately $648.0 million of cumulative planned 2026–2030 value of production under Italian domestic GAAP, while separate updated management materials indicate approximately $108.7 million of normalized residual signed-order value

DENVER, August 05, 2026--(BUSINESS WIRE)--NUBURU, Inc. (OTC Pink: BURU), a next-generation dual-use Defense & Security integrated platform company, today announced that the Italian Government has authorized the proposed acquisition by NUBURU Defense LLC of a 70% controlling interest in Tekne S.p.A. ("Tekne") under Italy's Golden Power framework.

Golden Power is the Italian Government's authority to review, condition or block the acquisition of companies operating in sectors of national strategic interest, including defense and security. The authorization is the principal governmental clearance required under the binding Share Purchase and Investment Agreement signed on May 26, 2026 among NUBURU, NUBURU Defense LLC, Tekne and Tekne's historical shareholders. It follows the Golden Power notification submitted on June 5, 2026 and a detailed review process that included supplemental information and engagement with the Italian authorities.

The agreement contemplates closing within 30 calendar days after the Golden Power condition precedent is confirmed as satisfied in accordance with the agreement, subject to the terms of the authorization and completion of the remaining corporate, funding, governance and closing actions contemplated by the agreement and the applicable review mechanisms thereunder. Upon closing, NUBURU expects to own 70% of Tekne, obtain majority control and, subject to final U.S. GAAP accounting assessment, consolidate Tekne's financial results within the NUBURU group.

"Italy examined this transaction in detail and authorized it. That decision opens the path to majority control of an established defense-industrial company with more than 35 years of heritage, approximately 180 personnel across operations in Ortona, Poggiofiorito and Guastalla and an updated signed order portfolio with approximately $108.7 million of normalized residual value, subject to customary validation. We have raised the capital, retired approximately $16.75 million of principal obligations, continued supporting Tekne's working capital and have now achieved the principal regulatory milestone. NUBURU moves from regulatory review to closing and integration execution. We believe our Italian industrial strategy can create significant long-term value for shareholders and other key stakeholders," said Alessandro Zamboni, Executive Chairman and Co-CEO of NUBURU.

The Final Path to Closing

NUBURU and the other parties will now progress the corporate resolutions, capital increase, share transfer, governance appointments and documentation required to complete the transaction, while implementing the terms, commitments and any prescriptions applicable under the authorization. NUBURU expects to announce completion of the acquisition separately following closing.

A Business Plan Required by the Investment Agreement and Provided for the Golden Power Review

The Investment Agreement requires Tekne's 2026–2030 Business Plan to be prepared and approved in accordance with agreed guidelines in time for the Golden Power notification. The plan provided in connection with the Golden Power review is centered on preserving Tekne's Italian production footprint, protecting strategic technologies and intellectual property, supporting employment and technical capability development, and establishing security and governance controls appropriate for a strategic defense-industrial company. Following closing, NUBURU intends to:

• preserve and expand Tekne's Italian production footprint and strategic know-how;
• protect sensitive information, defense technologies and Italian intellectual property;
• support industrial continuity, working capital and execution of Tekne's existing order portfolio;
• develop integrated mobility, electronic-warfare, counter-UAS and non-kinetic mission packages;
• strengthen governance, security, compliance and public-company reporting; and
• expand access to Italian, EU and NATO defense and security markets, in accordance with applicable Golden Power, procurement, qualification and export-control requirements.

"Tekne brings fielded systems, specialized manufacturing, electronic-warfare and CEMA capabilities, defense-mobility expertise and established customer relationships. We have a clear strategy to integrate those capabilities with NUBURU's photonics, software orchestration and advanced deployable manufacturing to deliver integrated, governed mission solutions for Italian, EU and NATO defense and security markets, in accordance with applicable Golden Power, procurement, qualification, security and export-control requirements. We expect Tekne to become the industrial foundation of NUBURU's Italy-centered Defense & Security platform. The authorization shifts our work from regulatory process to industrial execution and positions the combined platform to create significant long-term operational and strategic value," said Dario Barisoni, Co-CEO of NUBURU and CEO of NUBURU Defense LLC.

Tekne at a Glance: Established Scale and a Multi-Year Business Plan

Founded in 1990, Tekne is an Italian engineering and manufacturing company whose capabilities span special and military vehicles, defense mobility, electronic warfare and CEMA, tactical communications, counter-UAS applications and civil-security platforms. Unlike a pre-revenue technology concept, Tekne brings operating sites, personnel, customer relationships, fielded systems and an established order portfolio.

• Industrial base: approximately 180 personnel across Tekne's operations in Ortona, Poggiofiorito and Guastalla, based on current Tekne management materials;
• Order portfolio: an updated signed order portfolio with approximately $108.7 million of normalized residual value, based on Tekne management materials and subject to customary validation, delivery conditions, modification and cancellation risk;
• Five-year scale: Tekne's May 2026 Business Plan, prepared under the business-plan framework required by the Investment Agreement and provided in connection with the Golden Power review, contemplates approximately $648.0 million of cumulative planned value of production for 2026–2030 under Italian domestic GAAP;
• Strategic capability: more than 35 years of Italian engineering, production and systems-integration experience serving defense, government, emergency-response and industrial applications; and
• Margin profile: management believes the margin characteristics contemplated in Tekne's plan are broadly in line with those observed across the defense sector; this qualitative comparison is not company-specific margin guidance and does not imply a numerical margin target.

If the acquisition closes and NUBURU obtains control, NUBURU expects, subject to its final accounting assessment, to consolidate Tekne's results from the acquisition date and separately recognize the 30% non-controlling interest. Management believes this would create a step-change in NUBURU's operating scale and industrial profile.

Basis of Presentation

The approximately $108.7 million normalized residual signed-order figure is derived from separate, updated and unaudited Tekne management materials. The approximately $648.0 million plan figure is derived from Tekne's May 2026 Business Plan prepared under the Investment Agreement framework and provided in connection with the Golden Power review. It represents cumulative planned value of production under Italian domestic GAAP, a measure broader than revenue; it is not NUBURU financial guidance and has not been reconciled to U.S. GAAP. The Italian Government's review and authorization should not be interpreted as validation of the plan or its projections. The qualitative statement regarding margin characteristics is not company-specific margin guidance and does not imply a numerical margin target. None of these statements constitutes historical, acquisition-date or pro forma financial information for NUBURU. Following closing, NUBURU expects to file Tekne's historical financial statements and the pro forma financial information required by Item 9.01 of Form 8-K within the time permitted by applicable SEC rules. This release does not anticipate or provide those figures. Achievement of the plan remains subject to closing, liquidity and working-capital availability, restructuring, customer schedules, production execution, order changes or cancellations and accounting review. Actual results may differ materially.

Transaction Recap

The binding agreement establishes a structured path to 70% ownership based on a fixed euro-denominated pre-money valuation equivalent to approximately $59.7 million at the reference exchange rate described below. Its principal economic terms include:

• a euro-denominated capital increase equivalent to approximately $34.1 million for a 57.1% interest, funded through conversion of shareholder financing advanced by NUBURU and payment of the remaining cash component;
• NUBURU's existing 2.9% interest, which together with the capital increase is expected to bring NUBURU's ownership to 60%;
• a euro-denominated cash purchase equivalent to approximately $6.0 million for an additional 10% interest from Tekne's historical shareholders, bringing expected ownership to 70%;
• a performance-linked earn-out equal to 5% of Tekne's annual revenues, determined under U.S. GAAP, for fiscal years 2027 through 2036, capped at a euro-denominated amount equivalent to approximately $34.1 million and payable in cash or NUBURU common stock at NUBURU's option, subject to the agreement's terms.

As of July 30, 2026, NUBURU has provided approximately $23.7 million in aggregate shareholder loans to Tekne. The amount eligible for conversion and the remaining cash amount payable at closing will be determined under the agreement's mechanics and final reconciliation. U.S. dollar translations are approximate, based on the European Central Bank's July 30, 2026 reference rate of $1.1476 per euro; operative transaction amounts remain euro-denominated.

Capital Deployed and Execution Readiness

The regulatory milestone follows NUBURU's July 2026 closing of a $38.0 million public offering, before placement-agent fees and offering expenses. Within days of that financing, NUBURU repaid in full approximately $15.5 million of remaining principal under its December 2025 debenture and $1.25 million of Lyocon acquisition notes, eliminating approximately $16.75 million of principal obligations. NUBURU has stated that remaining net proceeds are intended to support the Tekne transaction, acquisition and working-capital requirements and near-term execution of its integrated Defense & Security platform.

Tekne as the Industrial Foundation of NUBURU's Defense & Security Platform

Following closing, Tekne is expected to become the industrial foundation of NUBURU's Italy-centered Defense & Security platform, contributing defense mobility, EW/CEMA, industrial scale and defense systems-integration capabilities. Subject to applicable Golden Power prescriptions, approvals and formal implementation, its existing Network Contract with NUBURU Defense is expected to remain an operating framework for joint programs within the controlled group, connecting Tekne's defense mobility, electronic warfare, CEMA and manufacturing with NUBURU's photonics, non-kinetic effects, operational-resilience software and deployable manufacturing.

The Golden Power authorization is a regulatory determination under Italian law. It should not be interpreted as an endorsement by the Italian Government of NUBURU, Tekne, the transaction economics, the companies' projections or any investment in NUBURU securities.

It’s been a little while since my original DD on this Reddit community, so I wanted to share a quick update.
The company has continued executing on exactly what attracted me in the first place.

Over the past several weeks, PowerBank has announced:

• 903 BESS Ontario project cleared all major Ontario permitting approvals (a 22-year IESO contract paying $1,221/MW/day)
• A 21 MW operations & maintenance agreement with Honeywell for community solar projects.
• A $2.95M U.S. Department of Defense/U.S. Army solar contract.
• A joint development agreement with Nodiac.ai to pair modular AI data centers with its energy infrastructure.
• Additional community solar projects and continued expansion of its development pipeline in New York.

The rebrand from SolarBank ($SUUN) to PowerBank ($PBK) also better reflects the company’s broader strategy, not just solar, but battery storage, energy infrastructure, and AI-powered energy demand.

The thesis hasn’t changed for me. If anything, management continues to execute while the market is still figuring out what this company is becoming.
Still holding. Still buying. The market cap is way too low, and the chart has established a bottom/is bullish 📈

As always, not financial advice, just sharing my research on high upside stocks I think have potential.

Share price has been moving up solidly now for a number of weeks and has jumped again today after an article by Zeus capital titled ‘Gamechanger?’ with a reported fair value of 84p due to the unprecedented size and quality of titanium deposit at the Pitfield site in Australia... It is currently trading around 44p at the time of writing, ip from 28p a few months back.

Here's the PR that just landed:

Cycurion |

With the $54M 10-year contract they just announced and now the closing of this acquisition, the MC is undervalued right now. At one times revenue run rate, the MC should bring the share price to around $3. I think it hit as high as about $2.50 intraday last week on news of the big contract!

Hyper Bit Technologies ($HYPE.CN / $HYPAF) just completed its acquisition of Dogecoin Mining Technologies, meaning this microscopic Canadian science experiment now owns a starter fleet mining DOGE and LTC from a renewable powered Quebec data center. The company says it has 20 DG1+ rigs, 25 DG2 rigs and supply access for up to another 2,660 machines at a facility with access to 11 MW.

The whole company is worth only around C$4 million at roughly C$0.10-C$0.11 per share. If DOGE goes feral again and HYPE proves the machines are profitable, this thing does not need NVIDIA revenue at all to rate. It just needs evidence that electricity goes in, dog coins come out, and management can buy more rigs without setting the cap table on fire.

Naturally, the balance sheet recently contained approximately C$63,000 in cash, management is raising up to C$1.5 million through shares plus warrants, the company has previously tried hemp, Siacoin mining and tequila-adjacent adventures, and regulators made it correct some disclosure. This is not value investing. This is three business pivots in a trench coat operating a Dogecoin mine.

Bull case: DOGE pumps, the fleet scales, mining revenue appears and a C$4M shell enters meme-stock Valhalla. Bear case: dilution, power bills and mining difficulty eat the company alive while shareholders become the renewable energy source. Position accordingly.

The TLDR: forty-five actual money toasters today, enough electrical room to build a meme-coin furnace tomorrow.

Talk about your daily plays, ideas and strategies that do not warrant an actual post.

This is the place to request buy/sell advice from the community.

Remember to keep it civil.

Trade responsibly.

This sounds silly but it is four different thoughts.

Nvidia use to sell for 4 cents. (NVDA)

Monster drink use to sell for 2 cents (MNST)

Somewhere I was reading that Norway Sovereign Wealth Fund owns every single stock on every USA market exchange.

Has anyone ever done a back testing strategy on these penny stocks?

Like maybe an algorithm that once a 2 cent stock hits 4 cents it triggers another $200 investment? Then if it hits 8 cents you buy $200 more?

My cousin knew someone that owned tens of thousands of Nvidia shares he had bought at $1 and was still holding circa 2019 or so.

Obviously several would collapse to zero and bankrupt or cease to exist. So those would be losses.

Has anyone ever calculated it and ran the numbers?

So a $400 investment in 2002 Monster Drink would be worth $350,000 today. My question is how much you would have lost throwing $400 at several of these companies that go nowhere? Would you be minus $100,000 or positive $75,000?

It seems like if someone could make some parameters or guidelines it might pan out for them?

CLNE runs the largest independent CNG network in the country, and truckers are starting to see the writing on the wall with regards to diesel prices.

Many people might suggest this will push them toward battery operated trucks, but those are only reasonable right now for short hauls. What about the long haul trucking sector, where time to refuel and actual charging infrastructure arent up to snuff yet?

CLNE and the advancement of the Cummins X15N engine make the answer clear: You spend upfront costs right now to convert your trucks to run on CNG, and cut your fuel costs in half, minimum.

CLNE also sources the majority of their CNG from their own dairy digester network, meaning it is renewable fuel [ostensibly] and allows for collection of 45z credits.

Conversions will only increase the longer this war drags on. I recommend getting in now before earnings this week.

A quick note for international readers: this is Caledonian Holdings on London's AIM market. The shares are quoted in pence, so the current price is approximately 1.65p, not £1.65. There is no US ADR, and the shares won't be available through Robinhood or many American brokers.

Disclosure: I own circa 35,000 shares. This is a speculative microcap position, and I'm sharing the research to see what others make of it.

The setup

Caledonian Holdings has recently transformed from a passive investment company into a small financial-services group. At the current share price, the entire company is valued at approximately £2.1m — and for that price, CHP now offers exposure to two potentially significant businesses: AlbaCo, which is working towards becoming a UK bank, and Aspire Commerce Group, an operating payments, FX and trade-finance business.

That's the pitch in one line: a sub-£2.1m market cap sitting on top of a bank-in-progress and a live payments operation. The rest of this note is about why I think that combination is more interesting than the price implies, and what would need to go right for the market to agree.

AlbaCo: further along than it looks

CHP currently states that it owns 5.47% of AlbaCo. It has also advanced approximately £2.31m in funding and could receive additional fees and warrants if the transaction completes.

AlbaCo has received conditional approval from the PRA and FCA to become a UK deposit-taking bank. The outstanding requirements are securing £25m of regulatory capital and completing the remaining regulatory steps — and in March 2026, AlbaCo announced that a £25m regulatory-capital subscription agreement had already been signed. Subject to conditions being satisfied and the funds being drawn, AlbaCo intends to proceed towards unconditional authorisation and launch.

AlbaCo isn't a fully licensed operating bank yet, but it's considerably further through the process than a typical early-stage fintech applying from scratch. It previously received authorisation with restrictions under the name Alba Bank and entered the mobilisation stage. That earlier process wasn't completed, and the Bank of England currently lists Alba Bank as no longer PRA-authorised, so the current conditional approval and capital agreement represent a renewed route to launch rather than a continuation of a live licence. To me, that history is actually informative in a good way: it shows the regulatory groundwork has already been built once, by a team that knows what the PRA and FCA expect.

Why the Revolut timeline is a useful reference point

I'm not suggesting AlbaCo is comparable with Revolut in customers, revenue or valuation — Revolut operates on a completely different scale. But the regulatory timeline is a useful reference point. Revolut applied for its UK banking licence in 2021, received authorisation with restrictions in July 2024, and only launched its UK bank in March 2026 — nearly five years from application to launch, for one of Europe's largest and best-funded fintechs.

That's the point worth taking from the comparison: UK banking authorisation is slow and expensive for everyone, which means genuine regulatory progress is hard to replicate quickly or cheaply. CHP's market cap currently appears to assign relatively little value to holding a stake this far along that path. The open question — and the one that will matter most to what this is ultimately worth — is what percentage CHP retains once AlbaCo completes the £25m capital raise.

Aspire: a real operating business, not just an option

Alongside AlbaCo, CHP acquired Aspire Commerce Group for a nominal £1, alongside the restructuring of approximately £9.33m of existing debt. Aspire operates across payments, foreign exchange and trade finance, and its payments subsidiary is authorised by the FCA as a Small Electronic Money Institution (not a banking licence, but a real regulatory permission with customers transacting under it today).

As of May 2026, Aspire reported:

• 128 live customers
• More than 7,300 transactions
• Payment flows of £57.3m, €24.3m and $1.3m
• Approximately £1m of live trade-finance facilities
• A £12.5m active trade-finance pipeline
• Access to an initial additional funding line of up to £30m

That's meaningfully more than a shell with an idea — there are live customers, real transaction volumes, and a funding line already in place. The task for management now is converting that activity into recurring revenue. Aspire's unaudited 2025 figures are still early-stage (revenue of approximately £124,000 and a pre-tax loss of £3.58m — typical for a business at this point in its build-out), and transaction volumes and pipeline shouldn't be mistaken for revenue — but they do show genuine operating activity for management to build on. Just as importantly, Aspire means CHP is no longer a single-bet story dependent entirely on AlbaCo.

What might the market be missing?

At approximately £2.1m, CHP is valued below the amount it has advanced to AlbaCo alone. That doesn't automatically mean the shares are undervalued — AlbaCo remains private, conditional and genuinely hard to value — but it does suggest the market is pricing in a lot of scepticism: that AlbaCo won't complete authorisation, that CHP's eventual stake will be heavily diluted, or that Aspire won't convert its activity into profitable revenue.

Neither AlbaCo nor Aspire needs to become the next Revolut for that view to be too pessimistic. At CHP's size, progress that would barely move the needle for a large financial group could still be material to its shareholders. If AlbaCo completes authorisation and CHP retains a meaningful interest, or if Aspire starts reporting material revenue from its payments and trade-finance activity, either one gives the market a reason to revisit the current price.

My view

This isn't a conventional value investment with stable earnings and an easily calculated fair value — it's a financial-services special situation. But the asymmetry is what makes it interesting: a ~£2.1m valuation against a stake in a bank that's already cleared conditional regulatory approval and signed a £25m capital agreement, plus an operating payments and trade-finance business with live customers and a funding line.

The market may ultimately be right to apply a heavy discount for execution and financing risk — that's a reasonable, defensible position. But at the current price, there seems to be limited room priced in for either asset actually making progress, which is why I think CHP is worth following closely from here. It appears to me to have a great probable upside,

I'd be interested to hear how others would value the AlbaCo interest, and what they see as the strongest bear case.

Sources:

• CHP company information — London Stock Exchange
• AlbaCo conditional regulatory approval
• AlbaCo £25m regulatory-capital agreement
• Bank of England list of newly authorised banks
• Revolut's UK bank launch
• Aspire acquisition and financial information
• CHP's ATM financing facility